Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT02234102

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Prof. Dr. med. Bernd Lemke (from the registry)
Registry
  • NCT NCT02234102
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02234102. Non-randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Endoscopically guided laser ablation HeartLight system
Lead sponsor
Prof. Dr. med. Bernd Lemke (class: other)

Record details

Record id
cardio:ct-nct02234102
Content hash
5dac0c9a0fb9769de0219990a5da5a9c0868821f500bbd95de503dc4b5d6552e